Literature DB >> 33473253

Toward radiomics for assessment of response to systemic therapies in lung cancer.

Shawn Sun1, Florent L Besson2, Binsheng Zhao1, Lawrence H Schwartz1, Laurent Dercle1.   

Abstract

This editorial comment explains recent developments in radiomics regarding the use of quantitative imaging biomarkers to predict lung cancer sensitivity to a variety of cancer therapies. Tumor response assessment has been a crucial component guiding cancer treatment. Evaluation of treatment response was standardized and classically based on measuring changes in tumor lesion size. Recent breakthroughs in artificial intelligence pave the way for the use of radiomics in tumor response assessment. Such objective techniques would bring a remarkable transformation to conventional methods, which can be inherently subjective. Successful implementation of these technologies would allow for faster and more accurate predictions of treatment efficacy, which will be critical to the advancement of personalized medicine. Copyright:
© 2020 Sun et al.

Entities:  

Keywords:  computed tomography; immunotherapy; lung cancer; positron emission tomography; prognosis

Year:  2020        PMID： 33473253      PMCID： PMC7771714          DOI： 10.18632/oncotarget.27847

Source DB:  PubMed          Journal:  Oncotarget        ISSN： 1949-2553


  20 in total

1.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

Review 2.  iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics.

Authors:  Lesley Seymour; Jan Bogaerts; Andrea Perrone; Robert Ford; Lawrence H Schwartz; Sumithra Mandrekar; Nancy U Lin; Saskia Litière; Janet Dancey; Alice Chen; F Stephen Hodi; Patrick Therasse; Otto S Hoekstra; Lalitha K Shankar; Jedd D Wolchok; Marcus Ballinger; Caroline Caramella; Elisabeth G E de Vries
Journal:  Lancet Oncol       Date:  2017-03-02       Impact factor: 41.316

Review 3.  Radiomics: the bridge between medical imaging and personalized medicine.

Authors:  Philippe Lambin; Ralph T H Leijenaar; Timo M Deist; Jurgen Peerlings; Evelyn E C de Jong; Janita van Timmeren; Sebastian Sanduleanu; Ruben T H M Larue; Aniek J G Even; Arthur Jochems; Yvonka van Wijk; Henry Woodruff; Johan van Soest; Tim Lustberg; Erik Roelofs; Wouter van Elmpt; Andre Dekker; Felix M Mottaghy; Joachim E Wildberger; Sean Walsh
Journal:  Nat Rev Clin Oncol       Date:  2017-10-04       Impact factor: 66.675

4.  Responsible Radiomics Research for Faster Clinical Translation.

Authors:  Martin Vallières; Alex Zwanenburg; Bodgan Badic; Catherine Cheze Le Rest; Dimitris Visvikis; Mathieu Hatt
Journal:  J Nucl Med       Date:  2017-11-24       Impact factor: 10.057

5.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

Review 6.  Immunotherapy response assessment in neuro-oncology: a report of the RANO working group.

Authors:  Hideho Okada; Michael Weller; Raymond Huang; Gaetano Finocchiaro; Mark R Gilbert; Wolfgang Wick; Benjamin M Ellingson; Naoya Hashimoto; Ian F Pollack; Alba A Brandes; Enrico Franceschi; Christel Herold-Mende; Lakshmi Nayak; Ashok Panigrahy; Whitney B Pope; Robert Prins; John H Sampson; Patrick Y Wen; David A Reardon
Journal:  Lancet Oncol       Date:  2015-11       Impact factor: 41.316

7.  Stability of radiomics features in apparent diffusion coefficient maps from a multi-centre test-retest trial.

Authors:  Jurgen Peerlings; Henry C Woodruff; Jessica M Winfield; Abdalla Ibrahim; Bernard E Van Beers; Arend Heerschap; Alan Jackson; Joachim E Wildberger; Felix M Mottaghy; Nandita M DeSouza; Philippe Lambin
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

8.  Deep learning and radiomics in precision medicine.

Authors:  Vishwa S Parekh; Michael A Jacobs
Journal:  Expert Rev Precis Med Drug Dev       Date:  2019-04-19

9.  Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma.

Authors:  Nabil Elshafeey; Aikaterini Kotrotsou; Ahmed Hassan; Nancy Elshafei; Islam Hassan; Sara Ahmed; Srishti Abrol; Anand Agarwal; Kamel El Salek; Samuel Bergamaschi; Jay Acharya; Fanny E Moron; Meng Law; Gregory N Fuller; Jason T Huse; Pascal O Zinn; Rivka R Colen
Journal:  Nat Commun       Date:  2019-07-18       Impact factor: 14.919

10.  Response Criteria for Intratumoral Immunotherapy in Solid Tumors: itRECIST.

Authors:  Gregory V Goldmacher; Anuradha D Khilnani; Robert H I Andtbacka; Jason J Luke; F Stephen Hodi; Aurelien Marabelle; Kevin Harrington; Andrea Perrone; Archie Tse; David C Madoff; Lawrence H Schwartz
Journal:  J Clin Oncol       Date:  2020-06-18       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.